glucagon has been researched along with Adenocarcinoma of Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Min, S; Zheng, Q; Zhou, Q | 1 |
Bae, H; Chun, SK; Fortin, BM; Goodson, MO; Jang, C; Masri, S; Verlande, A | 1 |
2 other study(ies) available for glucagon and Adenocarcinoma of Lung
Article | Year |
---|---|
Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases.
Topics: Adenocarcinoma of Lung; Adenylyl Cyclases; Aged; Biomarkers, Tumor; Calcitonin Gene-Related Peptide; Databases, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Glucagon; GTP-Binding Protein gamma Subunits; Humans; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prognosis; Protein Interaction Maps; Receptors, Adrenergic, beta-2; Receptors, G-Protein-Coupled; Transcriptome | 2021 |
Glucagon regulates the stability of REV-ERBĪ± to modulate hepatic glucose production in a model of lung cancer-associated cachexia.
Topics: Adenocarcinoma of Lung; Animals; Cachexia; Circadian Rhythm; Glucagon; Glucose; Liver; Lung Neoplasms; Mice; Nuclear Receptor Subfamily 1, Group D, Member 1 | 2021 |